Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

NCT00003452 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Stage IV Bladder Cancer

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute